Methampetamine Precursor Electronic Tracking
Board of Pharmacy DOH Website
Anticipated Enforcement date – October 15, 2011
The 2010 Washington Legislature passed RCW 69.43.110 to restrict the sale and purchase of nonprescription products containing ephedrine, pseudoephedrine, and phenylpropanolamine or their salts or isomers, or salts of isomers. The law:
- Requires pharmacies to keep products containing methamphetamine precursors behind the counter where the public is not permitted or in a locked display case where it is not accessible to customers without assistance;
- Requires the retailer to record the name and address of the purchase, the date and time of the sale, the name and the initials of the person conducting the transaction, the name of the product sold, and the total quantity in grams of the precursors being sold;
- Requires the customer to electronically or manually sign a record of any transactions when purchasing methamphetamine precursors;
- Updates the sales limits to match the federal restrictions – daily sales limit of 3.6 grams per purchaser and prohibits a purchaser from buying more than nine grams during a 30-day period; and
- Requires the Board of Pharmacy to implement a real-time electronic sales tracking system.
Methamphetamine Precursor Electronic Tracking/Monitoring System
The National Precursor Log Exchange (NPLEx) will:
- Be provided without cost to retailers. This does not include costs relating to Internet access, optional hardware, or other equipment.
- Immediately notify the retailer if a sale will exceed legal limits.
- Allow the retailer to override the stop-sale alert if the retailer is in reasonable fear of imminent bodily harm.
- Be accessible to law enforcement for investigative purposes.
Optional Scanners: The NPLEx retail Web portal does not require any scanner hardware. However, pharmacies interested in further enhancing their workflow have the option of purchasing scanners that will scan 2D Driver’s License, product UPC, and capture signature. The board does not require any scanners to participate in NPLEx. If your pharmacy is interested in obtaining more information on a scanner or have more questions, please email WANPLEx@appriss.com.
Point-of-Sale Integration: Appriss, the software provider of NPLEx, has also completed or is in the process of developing integrations with several point-of-sale (POS) vendors. By integrating with the POS software, transactions can be submitted directly to NPLEx from your POS system instead of using the NPLEx retail Web portal. For more information on whether you can integrate your POS vendor with NPLEx, please have your POS vendor contact Appriss at WANPLEx@appriss.com.
Unless granted an exemption by the board in accordance with RCW 69.43.110, your participation is required.
Frequently Asked Questions – Reporting, Exemption and Access
Reporting to the Electronic Tracking System:
Washington State statute requires any pharmacy, shopkeeper, or itinerant vendor (retailers) that sells over-the-counter (nonprescription) medicines that contain ephedrine, pseudoephedrine or phenylpropanolamine (PSE) to report certain purchaser and sales information to a statewide electronic database. Reporting to the electronic database replaces the current requirement to record purchaser and sales information in a written logbook.
I am a pharmacy or retailer but I do not sell products that contain ephedrine and related compounds. Do I need to use the electronic monitoring system and should I apply for an exemption?
No. The requirement does not apply to pharmacies or retailers that do not sell nonprescription products that contain ephedrine, pseudoephedrine or phenylpropanolamine (PSE). Therefore, you are not required to report to the statewide database and you do not need to request an exemption.
I am a pharmacy that only sells products that contain ephedrine and related compounds under a prescription. Do I need to use the electronic monitoring system and should I apply for an exemption?
No. The requirement does not apply to pharmacies that sell products that contain ephedrine, pseudoephedrine or phenylpropanolamine (PSE) under a prescription written by an authorized practitioner. Therefore, your pharmacy is not required to report to the statewide database and is not required to request for exemption.
- Exemption from Reporting to the Electronic Tracking System:
Washington law provides an exemption for pharmacies/retailers that can demonstrate good cause why they are unable to comply with electronic reporting requirements. Good cause includes, but is not limited to, situations where the installation of the necessary equipment to access the tracking system is unavailable or cost prohibitive. Retailers who believe they are eligible under this provision may submit an exemption request form with the Washington State Board of Pharmacy. The board will review the request for exemption, and will grant or deny the request. The exemption may not exceed 180 days; however, a pharmacy/retailer may request additional exemptions if needed. Pending approval of an exemption and if the exemption is granted the pharmacy/retailer must maintain a product transaction log for all sales involving restricted products.
- Access to the Electronic Monitoring System:
Appriss, the technology provider for the National Precursor Log Exchange (NPLEx) system will mail letters between August 1 and 10, 2011 to all pharmacies. The letter will include NPLEx account information, instructions on accessing the system and training opportunities.
I have not received any information from Appriss and the date to begin reporting in my letter has already passed or it is very near. What do I need to do?
The first reporting date in the letter is a date that will allow retailers to begin reporting when the NPLEx account information is received. October 1, 2011 is the board’s anticipated enforcement date; however, you may begin reporting as soon as you receive your account information from Appriss.
I received my account information from Appriss but I am having problems accessing the NPLEx system. What do I need to do?
Contact Appriss’ customer support center by sending an email to WANPLEx@appriss.com or contact them by phone at 855.926.7539.